ArticleSurgical case reports2020

Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case report.

Takaaki Arigami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.